Nature Made® Introduces Advanced Multivitamin Gummies with a Unique Combination of 20 Essential Nutrients to Help Consumers Get the Daily Nutritional Support They Need

The assortment delivers 60 percent more total nutrients than current Nature Made Multivitamin Gummies to address a wider range of consumer lifestyle needs WEST HILLS, Calif.–(BUSINESS WIRE)–Nature Made, the leading national vitamin and supplement broadline brand with over 50 years of delivering high-quality products backed by science, today expands its existing Multivitamin portfolio with the … [Read more…]

Chegg Announces 2nd Annual Global Student Mental Health Week Amid Growing Loneliness Epidemic

Global organizations join Chegg to elevate conversations around student mental health, taking place February 26 – March 3. SANTA CLARA, Calif.–(BUSINESS WIRE)–Chegg, Inc. (NYSE: CHGG), today announced that it has partnered with esteemed non-profits and organizations from around the world for Global Student Mental Health Week 2024, taking place from February 26 to March 3. … [Read more…]

Rocket Pharmaceuticals Announces Update on FDA Review Timeline of KRESLADI™ (marnetegragene autotemcel) for the Treatment of Severe Leukocyte Adhesion Deficiency-I (LAD-I)

New Prescription Drug User Fee Act (PDUFA) date of June 30, 2024 CRANBURY, N.J.–(BUSINESS WIRE)–Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today announced the U.S. Food and Drug Administration (FDA) has extended the Priority Review period for … [Read more…]

European Commission Approves First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY™ (exagamglogene autotemcel), for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia

– Over 8,000 patients 12 years of age and older with severe sickle cell disease or transfusion-dependent beta thalassemia may be eligible for treatment – LONDON–(BUSINESS WIRE)–Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced today that the European Commission has granted conditional marketing authorization to CASGEVY™ (exagamglogene autotemcel [exa-cel]), a CRISPR/Cas9 gene-edited therapy. CASGEVY is approved for … [Read more…]

Otsuka Announces Phase 3 Topline Results of AVP-786 in the Treatment of Agitation Associated With Dementia Due to Alzheimer’s Disease

PRINCETON, N.J. & TOKYO–(BUSINESS WIRE)–Otsuka Pharmaceutical Development & Commercialization, Inc., (OPDC) and our parent company Otsuka Pharmaceutical, Co. Ltd. (Otsuka) announce topline results of the phase 3 clinical trial of AVP-786 in the treatment of agitation associated with dementia due to Alzheimer’s disease (Trial 17-AVP-786-305; NCT03393520). A statistically significant difference was not achieved on the … [Read more…]

Flinn Foundation Adds Two Phoenix Business Leaders to Its Board of Directors

PHOENIX–(BUSINESS WIRE)–#Arizona–Arizona business leaders Chris Camacho and Adam Goodman—the heads of Greater Phoenix Economic Council and Goodmans, respectively—have been elected to the Flinn Foundation board of directors. Camacho, an advocate for the biosciences, other innovation industries, and the arts has served as president and CEO of the economic development organization for nearly a decade–an era … [Read more…]

Maximus Awarded Mental Health Assessments Contract From South Dakota’s Department of Social Services (DSS)

Maximus Becomes First Vendor in State to Conduct Preadmission Screening and Resident Review Assessments for Individuals Entering Long-Term Care Facilities TYSONS, Va.–(BUSINESS WIRE)–Maximus, a leading employer and provider of government services worldwide, today announced it has been selected by the state of South Dakota’s Department of Social Services (DSS) to administer mental health assessments of … [Read more…]

Chemical Insights Research Institute Scientist Honored for Technical Innovation and STEM Education

ATLANTA–(BUSINESS WIRE)–#beyastem38–Dr. Christa Wright of Chemical Insights Research Institute (CIRI) of UL Research Institutes, will receive the Outstanding Technical Contribution in Industry Award at the 2024 Black Engineer of the Year Award (BEYA) STEM (science, technology, engineering and mathematics) Conference on Feb 17, 2024, in Baltimore, Md. Dr. Wright is the Director of the Center … [Read more…]

Precision BioSciences Receives Initial $7.5 Million Cash Payment and Equity Investment from TG Therapeutics for Azel-Cel in Treatment of Autoimmune Diseases

DURHAM, N.C.–(BUSINESS WIRE)–Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene elimination, insertion, and excision, today received an upfront cash payment and equity investment from TG Therapeutics, Inc. (Nasdaq: TGTX) for an exclusive license to … [Read more…]

Depixus wins SLAS2024 Ignite Award for MAGNA™ technology

PARIS–(BUSINESS WIRE)–Interactomics pioneer Depixus has won the prestigious Society for Laboratory Automation and Screening (SLAS) Ignite Award at the society’s annual International Conference and Exhibition in Boston, MA, for their novel MAGNA™ technology. The award coincides with the first showing of Depixus’ ground-breaking MAGNA One™ instrument at the conference. The Ignite Award recognizes exciting companies … [Read more…]